June 10, 2022 — According to a new study, use of breast imaging services  —  including mammography screening — may remain at only 85.3% of pre-pandemic utilization (March through May 2019).

June 10, 2022 — Targeted text reminders and other interventions erased disparity in the rate of breast cancer screening between economically advantaged and disadvantaged patients, according to an OSF HealthCare study published

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer – the most prevalent cancer in men and the third most prevalent cancer overall[i].


Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from various vendors, offering a side-by-side, apples-to-apples comparison when making purchasing decisions. These charts can save hours of research, and offer links back to the websites of each vendor for additional information. The charts were created by ITN by sending out a questionnaire to each of the vendors listed. 


June 9, 2022 — Infinitt North America and Brainreader A/S announced today a wide ranging and unique partnership to expand and deepen the use of Brainreader's FDA cleared Neuroreader software. Neuroreader Report analyzes an MRI sequence to determine whether brain structures are abnormal and to what extent.


The "Mobile Imaging Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.


June 9, 2022  — DetectedX announced that it has been selected by the National Breast Screening Programme in Ireland, BreastCheck, to provide access to its Radiology Online Learning Platform to radiologists participating in the Screening Programme.

June 8, 2022 — MinXray continues to enhance the diagnostic capabilities of its digital radiography systems with the addition of qXR Automated Chest X-ray AI Solution from Qure.ai. The new AI software can detect and localize 30 chest X-ray abnormalities including TB and changes indicative of COVID-19 infections.

June 8, 2022 — Proscia, a leader in digital and computational pathology solutions, announced that its Concentriq Dx platform has been certified under the new

Subscribe Now